Novo Nordisk A/S
BMV:NVON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
BMV:NVON
|
DK |
|
Shake Shack Inc
LSE:0L5R
|
US |
|
N
|
Netflix Inc
LSE:0QYI
|
US |
|
Planigrupo Latam SAB de CV
BMV:PLANI
|
MX |
|
C
|
Capgemini SE
OTC:CAPMF
|
FR |
Wall St Price Targets
NVON Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for
NVON is 890.62 MXN with a low forecast of 539.49 MXN and a high forecast of 1 273.13 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVON's stock price target?
Price Target
890.62
MXN
According to Wall Street analysts, the average 1-year price target for
NVON is 890.62 MXN with a low forecast of 539.49 MXN and a high forecast of 1 273.13 MXN.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 1%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is -1%.